Disclosure Panels Details Page

Chronic Myeloid Leukemia Panel - Disclosures as of 06/05/2014

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Camille Abboud MD None Pfizer Inc. Agios, Inc.
Cardinal Health
Jazz Pharma
Jazz Pharmaceuticals
None NA
Mojtaba Akhtari MD None None None None NA -
Jessica Altman MD AbbVie, Inc.
ALX Oncology
Amgen Inc.
Aprea
Astellas Pharma US, Inc.
BioSight
Bristol-Myers Squibb Company
Cellectis
Fujifilm Corporation
Gilead Sciences, Inc.
GlycoMimetics, Inc.
ImmunoGen, Inc.
Kartos
Kura Oncology, Inc.
MEI Pharma Inc.
Rafael
AbbVie, Inc.
Astellas Pharma US, Inc.
GlycoMimetics, Inc. None NA
Ellin Berman MD Takeda Pharmaceuticals North America, Inc. None None None NA
Peter Curtin MD CRISPR Therapeutics None None None NA -
Daniel DeAngelo MD, PhD Daiichi- Sankyo Co.
Fibrogen
Mt Sinai MPN Consortium
None Amgen Inc.
Blueprint Medicines
Jazz Pharmaceuticals Inc.
Kite Pharma
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Servier
None NA
Michael Deininger MD, PhD ARIAD Pharmaceuticals, Inc.
Blueprint Medicines
Huntsman Cancer Institute
Leukemia & Lymphoma Society
Medical College of Wisconsin
Novartis Pharmaceuticals Corporation
Oregon Health & Science University
Pfizer Inc.
SPARC
Sun Pharma
V Foundation for Cancer Research
Blueprint Medicines
DisperSol
Fusion Pharma
Incyte Corporation
Medscape
Novartis Pharmaceuticals Corporation
Sangamo
Takeda Pharmaceuticals North America, Inc.
None None NA
Steven Devine MD sanofi-aventis U.S. Janssen Pharmaceutica Products, LP Kiadis
sanofi-aventis U.S.
None None
Amir Fathi MD AbbVie, Inc.
Bristol-Myers Squibb Company
Servier
AbbVie, Inc.
Agios, Inc.
Astellas Pharma US, Inc.
Blueprint Medicines
Bristol-Myers Squibb Company
Foghorn
Genentech, Inc.
Kite Pharma
Kura Oncology, Inc.
MorphoSys AG
Pfizer Inc.
Takeda Pharmaceuticals North America, Inc.
Trillium
None None NA
Fayna Ferkle PharmD None None None None None
Lauren Gallagher None None None None None
Jason Gotlib MD, MS AbbVie, Inc.
Blueprint Medicines
Bristol-Myers Squibb Company
Celgene Corporation
Deciphera Pharmaceuticals, Inc.
Incyte Corporation
Kartos
PharmaEssentia
Promedior, Inc.
Protagonist Therapeutics
AbbVie, Inc.
Blueprint Medicines
PharmaEssentia
Protagonist Therapeutics
None None NA
Kristina Gregory MSN, RN, OCN None None None None NA -
Madan Jagasia MD, MBBS, MMHC, MS None Incyte Corporation
Kadmon
Therakos, Inc.
None None NA -
Patricia Kropf MD None Astex Pharmaceuticals Celgene Corporation
Millennium Pharmaceuticals, Inc.
None NA -
Joan McClure MS None None None None NA
Joseph Moore MD Pharmacyclics None Pharmacyclics None NA
Arnel Pallera MD None None None None NA
Jerald Radich MD None Novartis Pharmaceuticals Corporation None None NA
Vishnu Reddy MD None Seattle Genetics, Inc. None None NA
Neil Shah MD, PhD Bristol-Myers Squibb Company
PTC Therapeutics
Sierra Oncology
None None None NA
B. Douglas Smith MD Celgene Corporation
Cellularity
Agios, Inc.
Jubilant
Novartis Pharmaceuticals Corporation
Pfizer Inc.
None None NA
David Snyder MD None None None None NA -
Hema Sundar PhD None None None None NA
Meir Wetzler MD Bristol-Myers Squibb Company
Cyclacel
MedPace
National Cancer Institute
OSU
Prime Oncology
Boehringer Ingelheim GmbH
Clinical Connexion
Dava
Envision
Intellsphere
McVeigh
MedLearning
P4 Healthcare
Sigma-Tao
WebMD
None None NA -